Literature DB >> 1335546

Association of hepatitis C virus in human sera with beta-lipoprotein.

R Thomssen1, S Bonk, C Propfe, K H Heermann, H G Köchel, A Uy.   

Abstract

Hepatitis C virus (HCV)-RNA in sera of patients with viral hepatitis C is supposed to be included, at least partially, into HCV particles. We found that the density of HCV-RNA-carrying material was variable, as determined by sucrose gradient density centrifugation (1.03-1.20 g/cm3). In some of the sera examined HCV-RNA was restricted to low densities between 1.03 and 1.08 g/cm3. In other sera additional densities of HCV-RNA were found distributed over the whole gradient with peaks at 1.12 and 1.17 and at 1.19-1.20 g/cm3. HCV-RNA banding at low densities could be completely co-precipitated with anti-beta lipoprotein, whereas HCV-RNA fractions of higher densities were only partially precipitated or not at all. In 8 of 20 sera directly examined, HCV-RNA could be completely and in 9 sera only partially co-precipitated by anti-beta lipoprotein. In 3 sera no significant precipitation could be observed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335546     DOI: 10.1007/bf00198849

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  14 in total

1.  Non-A, non-B hepatitis: toward the discovery of hepatitis C and E viruses.

Authors:  D W Bradley; K Krawczynski; M J Beach; M A Purdy
Journal:  Semin Liver Dis       Date:  1991-05       Impact factor: 6.115

Review 2.  Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis.

Authors:  Q L Choo; A J Weiner; L R Overby; G Kuo; M Houghton; D W Bradley
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

3.  [Inhibition of rubella virus hemagglutination. I. Properties of an inhibitor of rubella virus hemagglutination in vitro present in fetal calf serum].

Authors:  R Laufs; R Thomssen
Journal:  Arch Gesamte Virusforsch       Date:  1968

4.  Purification and characterization of a bovine acetyl low density lipoprotein receptor.

Authors:  T Kodama; P Reddy; C Kishimoto; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups.

Authors:  R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

6.  Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end.

Authors:  J H Han; V Shyamala; K H Richman; M J Brauer; B Irvine; M S Urdea; P Tekamp-Olson; G Kuo; Q L Choo; M Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

7.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents.

Authors:  D W Bradley; J E Maynard; H Popper; E H Cook; J W Ebert; K A McCaustland; C A Schable; H A Fields
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

9.  Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform.

Authors:  S M Feinstone; K B Mihalik; T Kamimura; H J Alter; W T London; R H Purcell
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

10.  The agents of non-A, non-B viral hepatitis.

Authors:  D W Bradley
Journal:  J Virol Methods       Date:  1985-04       Impact factor: 2.014

View more
  118 in total

1.  HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication?

Authors:  V Meier; S Mihm; P Braun Wietzke; G Ramadori
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor.

Authors:  S Wünschmann; J D Medh; D Klinzmann; W N Schmidt; J T Stapleton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 3.  Unique ties between hepatitis C virus replication and intracellular lipids.

Authors:  Eva Herker; Melanie Ott
Journal:  Trends Endocrinol Metab       Date:  2011-04-15       Impact factor: 12.015

4.  Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus.

Authors:  Holly Freedman; Michael R Logan; Darren Hockman; Julia Koehler Leman; John Lok Man Law; Michael Houghton
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

Review 5.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

6.  Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein.

Authors:  Zhenyong Keck; Wenyan Wang; Yong Wang; Patrick Lau; Thomas H R Carlsen; Jannick Prentoe; Jinming Xia; Arvind H Patel; Jens Bukh; Steven K H Foung
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

7.  Apolipoprotein c1 association with hepatitis C virus.

Authors:  Jean-Christophe Meunier; Rodney S Russell; Ronald E Engle; Kristina N Faulk; Robert H Purcell; Suzanne U Emerson
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes.

Authors:  Audrey Boyer; Seung Bum Park; Ynto S de Boer; Qisheng Li; T Jake Liang
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

9.  Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.

Authors:  Baptiste Jammart; Maud Michelet; Eve-Isabelle Pécheur; Romain Parent; Birke Bartosch; Fabien Zoulim; David Durantel
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

Review 10.  Complementary and alternative medications in hepatitis C infection.

Authors:  Dina L Halegoua-De Marzio; Jonathan M Fenkel
Journal:  World J Hepatol       Date:  2014-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.